Table 1.
COHORT 1 | P | COHORT 2 | P | |||||
---|---|---|---|---|---|---|---|---|
All patients (n = 90) | Insula+ (n = 57) |
Insula− (n = 33) | All patients (n = 105) | Insula+ (n = 74) | Insula− (n = 31) | |||
Age (years), mean (SD) | 73 (12) | 74 (13) | 71 (12) | 0.248 | 69 (12) | 68 (12) | 71 (11) | 0.252 |
Sex (male), % | 63 | 60 | 70 | 0.340 | 51 | 51 | 52 | 0.980 |
Admission NIHSS score, median (IQR) | 10 (4–17) | 14 (9–20) | 4 (2–8) | <0.001 | 17 (12–20) | 17 (12–20) | 12 (10–18) | 0.017 |
Glucose at admission, | 138 (56) | 131 (41) | 149 (75) | 0.162 | 128 (39) | 129 (43) | 126 (29) | 0.754 |
Large vessel occlusion, % | 83 | 89 | 71 | 0.005 | 96 | 97 | 94 | 0.580 |
Acute revascularization, % | 0.339 | 0.273 | ||||||
None | 15 | 12 | 18 | 5 | 3 | 10 | ||
IV only | 62 | 60 | 67 | 24 | 26 | 19 | ||
IA (±IV) | 23 | 28 | 15 | 71 | 71 | 71 | ||
24 h NIHSS score, median (IQR) | 5 (2–15) | 9 (4–19) | 2 (0–3) | <0.001 | 8 (3–16) | 10 (5–17) | 4 (1–12) | 0.001 |
Infarct volume (cc), median (IQR) | 18 (3–53) | 28 (17–82) | 2 (1–6) | <0.001 | 15 (5–53) | 25 (11–82) | 3 (0.2–10) | <0.001 |
Laterality (right/left), % | 48/52 | 53/47 | 41/59 | 0.277 | 48/52 | 50/50 | 42/58 | 0.450 |
Etiologic stroke subtype, % | 0.017 | 0.022 | ||||||
Cardioembolic | 43 | 51 | 29 | 50 | 53 | 36 | ||
Large vessel atherosclerosis | 19 | 14 | 29 | 18 | 16 | 24 | ||
Lacunar | 6 | 0 | 17 | 0 | 0 | 7 | ||
Undetermined etiology | 27 | 28 | 25 | 23 | 25 | 24 | ||
Other | 5 | 7 | 0 | 9 | 6 | 9 | ||
3-month mRS score, median (IQR) | 2 (1–4) | 2 (1–4) | 1 (0–2) | <0.001 | 3 (1–4) | 3 (2–5) | 1 (0–2) | 0.135 |
Death at 3 months, % | 12 | 18 | 3 | 0.050 | 11 | 15 | 3 | 0.105 |
Cause of death | 0.231 | 0.007 | ||||||
Cerebrovascular | 55 | 60 | 0 | 50 | 55 | 0 | ||
Cardiovascular | 18 | 20 | 0 | 17 | 18 | 0 | ||
Infection | 0 | 0 | 0 | 25 | 27 | 0 | ||
Unknown | 27 | 20 | 100 | 8 | 0 | 100 |
Abbreviations: NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale.